M. Laseur

592 total citations
11 papers, 428 citations indexed

About

M. Laseur is a scholar working on Pulmonary and Respiratory Medicine, Pediatrics, Perinatology and Child Health and Nutrition and Dietetics. According to data from OpenAlex, M. Laseur has authored 11 papers receiving a total of 428 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pulmonary and Respiratory Medicine, 2 papers in Pediatrics, Perinatology and Child Health and 2 papers in Nutrition and Dietetics. Recurrent topics in M. Laseur's work include Clinical Nutrition and Gastroenterology (2 papers), Antibiotic Use and Resistance (2 papers) and Cystic Fibrosis Research Advances (2 papers). M. Laseur is often cited by papers focused on Clinical Nutrition and Gastroenterology (2 papers), Antibiotic Use and Resistance (2 papers) and Cystic Fibrosis Research Advances (2 papers). M. Laseur collaborates with scholars based in Netherlands, United States and Italy. M. Laseur's co-authors include L.Th. van der Weele, H.J.A. Mensink, Frans Stellaard, C. M. A. Bijleveld, Deanna M. Minich, Henkjan J. Verkade, W. M. van Aalderen, Peter G. M. Mol, Rijk O. B. Gans and Flora M. Haaijer‐Ruskamp and has published in prestigious journals such as American Journal of Clinical Nutrition, Critical Care Medicine and Journal of Antimicrobial Chemotherapy.

In The Last Decade

M. Laseur

10 papers receiving 407 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Laseur Netherlands 8 122 92 80 76 58 11 428
David J. Rosenberg United States 13 51 0.4× 38 0.4× 65 0.8× 12 0.2× 64 1.1× 16 507
Marie‐Louise Trotman United States 7 51 0.4× 17 0.2× 34 0.4× 27 0.4× 6 0.1× 16 380
Michael Rice New Zealand 12 73 0.6× 65 0.7× 254 3.2× 57 0.8× 7 0.1× 30 501
Bhanu Prasad Canada 15 113 0.9× 62 0.7× 52 0.7× 54 0.7× 1 0.0× 82 688
J.M. Rodríguez-Barbero Spain 10 117 1.0× 26 0.3× 209 2.6× 67 0.9× 11 0.2× 28 502
Tarun Bhagnani United States 9 75 0.6× 35 0.4× 72 0.9× 40 0.5× 72 1.2× 16 331
Montserrat Pérez-Encinas Spain 12 66 0.5× 4 0.0× 65 0.8× 48 0.6× 18 0.3× 54 492
Victoria Hodgetts Morton United Kingdom 12 117 1.0× 6 0.1× 47 0.6× 55 0.7× 6 0.1× 50 628
Bailey Rr New Zealand 11 194 1.6× 225 2.4× 147 1.8× 41 0.5× 4 0.1× 55 571
Wing Aj United Kingdom 16 50 0.4× 19 0.2× 97 1.2× 19 0.3× 2 0.0× 27 610

Countries citing papers authored by M. Laseur

Since Specialization
Citations

This map shows the geographic impact of M. Laseur's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Laseur with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Laseur more than expected).

Fields of papers citing papers by M. Laseur

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Laseur. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Laseur. The network helps show where M. Laseur may publish in the future.

Co-authorship network of co-authors of M. Laseur

This figure shows the co-authorship network connecting the top 25 collaborators of M. Laseur. A scholar is included among the top collaborators of M. Laseur based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Laseur. M. Laseur is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Tóth, Gábor G., M. Laseur, Nic J.G.M. Veeger, et al.. (2006). Randomized Controlled Trial of Adjuvant Oral Dexamethasone Pulse Therapy in Pemphigus Vulgaris. Archives of Dermatology. 142(5). 570–6. 46 indexed citations
2.
Mol, Peter G. M., Jaap E. Wieringa, Rijk O. B. Gans, et al.. (2005). Improving compliance with hospital antibiotic guidelines: a time-series intervention analysis. Journal of Antimicrobial Chemotherapy. 55(4). 550–557. 61 indexed citations
3.
Mol, Peter G. M., et al.. (2005). Reliability of assessment of adherence to an antimicrobial treatment guideline. Journal of Hospital Infection. 60(4). 321–328. 12 indexed citations
4.
Zwaveling, Jan H., John K. Maring, I. J. Klompmaker, et al.. (2002). Selective decontamination of the digestive tract to prevent postoperative infection: A randomized placebo-controlled trial in liver transplant patients. Critical Care Medicine. 30(6). 1204–1209. 57 indexed citations
5.
6.
Minich, Deanna M., C. M. A. Bijleveld, W. M. van Aalderen, et al.. (1999). Fat malabsorption in cystic fibrosis patients receiving enzyme replacement therapy is due to impaired intestinal uptake of long-chain fatty acids. American Journal of Clinical Nutrition. 69(1). 127–134. 91 indexed citations
7.
Houten, Marlies A. van, M. Laseur, & Jan L. L. Kimpen. (1998). Shift in antibiotic prescribing patterns in relation to antibiotic expenditure in paediatrics. European Journal of Pediatrics. 157(6). 479–481. 10 indexed citations
8.
Laseur, M., et al.. (1997). A placebo‐controlled study of intravesical pentosanpolysulphate for the treatment of interstitial cystitis. British Journal of Urology. 79(2). 168–171. 95 indexed citations
9.
Minich, Deanna M., C. M. A. Bijleveld, W. M. C. van Aalderen, et al.. (1997). CYSTIC FIBROSIS PATIENTS ON ENZYME REPLACEMENT THERAPY HAVE AN IMPAIRED INTESTINAL SOLUBILIZATION OF LONG-CHAIN FATTY ACIDS. Journal of Pediatric Gastroenterology and Nutrition. 24(4). 475–475. 1 indexed citations
11.
Laseur, M., et al.. (1984). [Acute renal failure and nephrotic syndrome related to pirprofen].. PubMed. 13(5). 283–283. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026